Development

Articles

Merck KGaA (Darmstadt, Germany), a global pharmaceutical and chemical company, completed its acquisition of Millipore (Billerica, MA), a life-science company, last Thursday for an aggregate purchase price of roughly EUR 5.2 billion ($6.7 billion).

Merck KGaA Acquires Millipore and Founds New Divisions

Xcelience and Penn Form Joint Venture; Almac Appoints QA Director; And More.

Week of July 12, 2010: Company and People Notes: Xcelience and Penn Form Joint Venture; Almac Appoints QA Director; And More.

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

The US House of Representatives passed on July 1, 2010, HR 4899, the Supplemental Appropriations Act of 2010, which included provisions restricting patent settlements between innovator-drug and generic-drug companies, a move that drew criticism from both sectors of the pharmaceutical industry.

Drug Industry Criticizes Patent Settlement Provisions in House Spending Bill

Eli Lilly to Acquire Alnara Pharmaceuticals; Exelixis CEO Leaves for Biogen Idec; And More.

Week of July 5, 2010: Company and People Notes: Eli Lilly to Acquire Alnara Pharmaceuticals; Exelixis CEO Leaves for Biogen Idec; And More.

As generic divisions become the most-wanted acquisitions of Big Pharma, India's domestic industry may be thinning out.

Report from India

The functionality and performance of three types of commercial superdisintegrants were evaluated in the application of orally disintegrating tablets.

Comparison of Superdisintegrants in Orally Disintegrating Tablets

Technical Note: The authors investigated the variables important for calcium-alginate formation as well as dissolution.

Novel Suppository Design for HIV Chemoprophylaxis

Excipient manufacturers expand their products, services, manufacturing capacity, and technology positions.

Augmenting Excipient Functionality

Michelle Hoffman, editorial director of Pharmaceutical Technology.

After a spate of industrial disasters, the public seeks greater oversight of corporations-so does FDA.

A Word to the Unwise

Pfizer Suspends Tanezumab Program; Actavis Appoints CEO; And More.

Ingredients